{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:51:17Z","timestamp":1780685477992,"version":"3.54.1"},"reference-count":39,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["17ZR1417100"],"award-info":[{"award-number":["17ZR1417100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Background and objective:<\/jats:title>\n<jats:p>All-trans retinoic acid (ATRA) is only effective in acute promyelocytic leukemia (APL), but not in other subtype of acute myeloid leukemia (AML). Salinomycin targets tumor cells rather than non-tumorigenic cells, and WNT\/\u03b2-catenin pathway inhibition is one of the mechanisms of its anti-tumor activity. There is a crosstalk between RA and WNT\/\u03b2-catenin pathway. Here, we investigate the effect of the combination of salinomycin and ATRA (S+RA) in non-APL AML cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Apoptosis was evaluated by cell viability and Annexin-V assay. Cell differentiation was analyzed by CD11c expression and morphology. To explore the underlying mechanisms, Western blot analysis and mitochondrial transmembrane potentials (\uf044\uf059m) were used.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results &amp; Discussion:<\/jats:title>\n<jats:p>S+RA induced differentiation and apoptosis in AML cell lines and AML primary cells. S+RA inhibited the \u03b2-catenin signal pathway as determined by the decreased protein levels of \u03b2-catenin, the low-density lipoprotein receptor-related proteins 6 (LRP6), and its downstream proteins such as survivin, c-Myc, caspase-3\/7, cdc25A and cyclinD1 and reduced phosphorylation level of GSK3\u03b2 S9. S+RA also increased the protein levels of CCAAT\/enhancer-binding proteins (C\/EBPs) and PU.1 and collapsed \uf044\uf059m. The above molecular and cellular changes induced by S+RA were inhibited by \u03b2-catenin specific activator and promoted by \u03b2-catenin specific inhibitor.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>S+RA induced differentiation by \u03b2-catenin-inhibition-mediated up-regulation of C\/EBPs and PU.1 and suppression of c-Myc. S+RA triggered apoptosis through \u03b2-catenin-inhibition-regulated \uf044\uf059m collapse and caspase-3\/7 activation. Taken together, our findings may provide novel therapeutic strategies for AML patients by targeting the WNT\/\u03b2-catenin pathway.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520623666230110121629","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T06:03:02Z","timestamp":1673416982000},"page":"1074-1084","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation\nof Acute Myeloid Leukemia Cells by Inhibiting WNT\/\u03b2-Catenin Pathway"],"prefix":"10.2174","volume":"23","author":[{"given":"Hui-Min","family":"Xi","sequence":"first","affiliation":[{"name":"Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine\nat Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine\nat Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qin","family":"Weng","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine\nat Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sheng","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine\nat Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine\nat Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine\nat Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4372-8889","authenticated-orcid":true,"given":"Xun","family":"Cai","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine\nat Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"Kantarjian H.","year":"2021","unstructured":"Kantarjian H.; Kadia T.; DiNardo C.; Daver N.; Borthakur G.; Jabbour E.; Garcia-Manero G.; Konopleva M.; Ravandi F.; Acute myeloid leukemia: Current progress and future directions. Blood Cancer J 2021,11(2),41","journal-title":"Blood Cancer J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"Huang M.E.","year":"1988","unstructured":"Huang M.E.; Ye Y.C.; Chen S.R.; Chai J.R.; Lu J.X.; Zhoa L.; Gu L.J.; Wang Z.Y.; Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988,72(2),567-572","journal-title":"Blood"},{"key":"ref=3","first-page":"12","volume":"69","author":"Taciak B.","year":"2018","unstructured":"Taciak B.; Pruszynska I.; Kiraga L.; Bialasek M.; Krol M.; Wnt signaling pathway in development and cancer. J Physiol Pharmacol 2018,69(2),12","journal-title":"J Physiol Pharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature01593","volume":"423","author":"Reya T.","year":"2003","unstructured":"Reya T.; Duncan A.W.; Ailles L.; Domen J.; Scherer D.C.; Willert K.; Hintz L.; Nusse R.; Weissman I.L.; A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003,423(6938),409-414","journal-title":"Nature"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nri1529","volume":"5","author":"Staal F.J.T.","year":"2005","unstructured":"Staal F.J.T.; Clevers H.C.; WNT signalling and haematopoiesis: A WNT-WNT situation. Nat Rev Immunol 2005,5(1),21-30","journal-title":"Nat Rev Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/sj.leu.2404239","volume":"20","author":"Ysebaert L.","year":"2006","unstructured":"Ysebaert L.; Chicanne G.; Demur C.; De Toni F.; Prade-Houdellier N.; Ruidavets J-B.; Mansat-De Mas V.; Rigal-Huguet F.; Laurent G.; Payrastre B.; Manenti S.; Racaud-Sultan C.; Expression of \u03b2-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 2006,20(7),1211-1216","journal-title":"Leukemia"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.leu.2404732","volume":"21","author":"Mikesch J-H.","year":"2007","unstructured":"Mikesch J-H.; Steffen B.; Berdel W.E.; Serve H.; M\u00fcller-Tidow C.; The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 2007,21(8),1638-1647","journal-title":"Leukemia"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Wang Y.","year":"2010","unstructured":"Wang Y.; Krivtsov A.V.; Sinha A.U.; North T.E.; Goessling W.; Feng Z.; Zon L.I.; Armstrong S.A.; The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010,327(5973),1650-1653","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature12883","volume":"506","author":"Kode A.","year":"2014","unstructured":"Kode A.; Manavalan J.S.; Mosialou I.; Bhagat G.; Rathinam C.V.; Luo N.; Khiabanian H.; Lee A.; Murty V.V.; Friedman R.; Brum A.; Park D.; Galili N.; Mukherjee S.; Teruya-Feldstein J.; Raza A.; Rabadan R.; Berman E.; Kousteni S.; Leukaemogenesis induced by an activating \u03b2-catenin mutation in osteoblasts. Nature 2014,506(7487),240-244","journal-title":"Nature"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s00432-020-03407-3","volume":"146","author":"Cardona-Echeverry A.","year":"2020","unstructured":"Cardona-Echeverry A.; Prada-Arismendy J.; Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: How alterations in DNA methylation come into play in patients\u2019 prognosis. J Cancer Res Clin Oncol 2020,146(12),3097-3109","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1158\/1078-0432.CCR-17-1556","volume":"24","author":"Jiang X.","year":"2018","unstructured":"Jiang X.; Mak P.Y.; Mu H.; Tao W.; Mak D.H.; Kornblau S.; Zhang Q.; Ruvolo P.; Burks J.K.; Zhang W.; McQueen T.; Pan R.; Zhou H.; Konopleva M.; Cortes J.; Liu Q.; Andreeff M.; Carter B.Z.; Disruption of Wnt\/\u03b2-catenin exerts antileukemia activity and synergizes with FLT3 inhibition in FLT3-mutant acute myeloid leukemia. Clin Cancer Res 2018,24(10),2417-2429","journal-title":"Clin Cancer Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12185-016-2116-x","volume":"105","author":"Suknuntha K.","year":"2017","unstructured":"Suknuntha K.; Thita T.; Togarrati P.P.; Ratanachamnong P.; Wongtrakoongate P.; Srihirun S.; Slukvin I.; Hongeng S.; Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines. Int J Hematol 2017,105(2),196-205","journal-title":"Int J Hematol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/cancers12092696","volume":"12","author":"Takam Kamga P.","year":"2020","unstructured":"Takam Kamga P.; Dal Collo G.; Cassaro A.; Bazzoni R.; Delfino P.; Adamo A.; Bonato A.; Carbone C.; Tanasi I.; Bonifacio M.; Krampera M.; Small molecule inhibitors of microenvironmental Wnt\/\u03b2-catenin signaling enhance the chemosensitivity of acute myeloid leukemia. Cancers 2020,12(9),2696","journal-title":"Cancers"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0960-9822(00)80088-3","volume":"9","author":"Easwaran V.","year":"1999","unstructured":"Easwaran V.; Pishvaian M.; Salimuddin ; Byers S.; Cross-regulation of \u03b2-catenin-LEF\/TCF and retinoid signaling pathways. Curr Biol 1999,9(23),1415-1419","journal-title":"Curr Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e0143255","DOI":"10.1371\/journal.pone.0143255","volume":"10","author":"Zhu X.","year":"2015","unstructured":"Zhu X.; Wang W.; Zhang X.; Bai J.; Chen G.; Li L.; Li M.; All-trans retinoic acid-induced deficiency of the Wnt\/\u03b2-catenin pathway enhances hepatic carcinoma stem cell differentiation. PLoS One 2015,10(11),e0143255","journal-title":"PLoS One"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1089\/scd.2019.0065","volume":"28","author":"Wang S.","year":"2019","unstructured":"Wang S.; Huang H.; Xiang H.; Gu B.; Li W.; Chen L.; Zhang M.; Wnt signaling modulates routes of retinoic acid-induced differentiation of embryonic stem cells. Stem Cells Dev 2019,28(19),1334-1345","journal-title":"Stem Cells Dev"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317695035","volume":"39","author":"Dewangan J.","year":"2017","unstructured":"Dewangan J.; Srivastava S.; Rath S.K.; Salinomycin: A new paradigm in cancer therapy. Tumour Biol 2017,39(3)","journal-title":"Tumour Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3892\/or.2018.6513","volume":"40","author":"Zhao Y.","year":"2018","unstructured":"Zhao Y.; Zhong L.; Liu L.; Yao S.F.; Chen M.; Li L.W.; Shan Z.L.; Xiao C.L.; Gan L.G.; Xu T.; Liu B.Z.; Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells. Oncol Rep 2018,40(2),877-886","journal-title":"Oncol Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"73448","DOI":"10.18632\/oncotarget.11866","volume":"7","author":"Roulston G.D.R.","year":"2016","unstructured":"Roulston G.D.R.; Burt C.L.; Kettyle L.M.J.; Matchett K.B.; Keenan H.L.; Mulgrew N.M.; Ramsey J.M.; Dougan C.; McKiernan J.; Grishagin I.V.; Mills K.I.; Thompson A.; Low-dose salinomycin induces anti-leukemic responses in AML and MLL. Oncotarget 2016,7(45),73448-73461","journal-title":"Oncotarget"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.bbrc.2010.03.138","volume":"394","author":"Fuchs D.","year":"2010","unstructured":"Fuchs D.; Daniel V.; Sadeghi M.; Opelz G.; Naujokat C.; Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 2010,394(4),1098-1104","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1073\/pnas.1110431108","volume":"108","author":"Lu D.","year":"2011","unstructured":"Lu D.; Choi M.Y.; Yu J.; Castro J.E.; Kipps T.J.; Carson D.A.; Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl Acad Sci USA 2011,108(32),13253-13257","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1182\/blood.V83.11.3298.3298","volume":"83","author":"Li Y.P.","year":"1994","unstructured":"Li Y.P.; Said F.; Gallagher R.E.; Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-\u03b1. Blood 1994,83(11),3298-3302","journal-title":"Blood"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1080\/10428194.2021.1961231","volume":"62","author":"Lu H.","year":"2021","unstructured":"Lu H.; Li Z.; Ding M.; Liang C.; Weng X.; Sheng Y.; Wu J.; Cai X.; Trametinib enhances ATRA-induced differentiation in AML cells. Leuk Lymphoma 2021,62(14),3361-3372","journal-title":"Leuk Lymphoma"},{"key":"ref=24","first-page":"906","volume":"9","author":"Liang C.","year":"2019","unstructured":"Liang C.; Ding M.; Weng X.Q.; Sheng Y.; Wu J.; Li Z.Y.; Cai X.; Combination of enzastaurin and ATRA exerts dose-dependent dual effects on ATRA-resistant acute promyelocytic leukemia cells. Am J Cancer Res 2019,9(5),906-926","journal-title":"Am J Cancer Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"Tetsu O.","year":"1999","unstructured":"Tetsu O.; McCormick F.; \u03b2-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999,398(6726),422-426","journal-title":"Nature"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ccr.2011.03.010","volume":"19","author":"Vijayakumar S.","year":"2011","unstructured":"Vijayakumar S.; Liu G.; Rus I.A.; Yao S.; Chen Y.; Akiri G.; Grumolato L.; Aaronson S.A.; High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF\/\u03b2-catenin target gene, CDC25A. Cancer Cell 2011,19(5),601-612","journal-title":"Cancer Cell"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/sj.onc.1208433","volume":"24","author":"Ma H.","year":"2005","unstructured":"Ma H.; Nguyen C.; Lee K.S.; Kahn M.; Differential roles for the coactivators CBP and p300 on TCF\/\u03b2-catenin-mediated survivin gene expression. Oncogene 2005,24(22),3619-3631","journal-title":"Oncogene"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cells9010023","volume":"9","author":"Huang Y.H.","year":"2019","unstructured":"Huang Y.H.; Yeh C.T.; Functional compartmentalization of HSP60-survivin interaction between mitochondria and cytosol in cancer cells. Cells 2019,9(1),23","journal-title":"Cells"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"van de Wetering M.","year":"2002","unstructured":"van de Wetering M.; Sancho E.; Verweij C.; de Lau W.; Oving I.; Hurlstone A.; van der Horn K.; Batlle E.; Coudreuse D.; Haramis A.P.; Tjon-Pon-Fong M.; Moerer P.; van den Born M.; Soete G.; Pals S.; Eilers M.; Medema R.; Clevers H.; The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002,111(2),241-250","journal-title":"Cell"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/ijc.30662","volume":"140","author":"Song J.H.","year":"2017","unstructured":"Song J.H.; Park E.; Kim M.S.; Cho K.M.; Park S.H.; Lee A.; Song J.; Kim H.J.; Koh J.T.; Kim T.S.; L -Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)2 D3-induced myeloid differentiation in acute myeloid leukemia cells. Int J Cancer 2017,140(10),2364-2374","journal-title":"Int J Cancer"},{"key":"ref=31","first-page":"7836","volume":"12","author":"Li Z.Y.","year":"2020","unstructured":"Li Z.Y.; Liang C.; Ding M.; Weng X.Q.; Sheng Y.; Wu J.; Lu H.; Cai X.; Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells. Am J Transl Res 2020,12(12),7836-7854","journal-title":"Am J Transl Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1038\/leu.2016.146","volume":"30","author":"Sheng Y.","year":"2016","unstructured":"Sheng Y.; Ju W.; Huang Y.; Li J.; Ozer H.; Qiao X.; Qian Z.; Activation of wnt\/\u03b2-catenin signaling blocks monocyte-macrophage differentiation through antagonizing PU.1-targeted gene transcription. Leukemia 2016,30(10),2106-2109","journal-title":"Leukemia"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj20030426","volume":"376","author":"Moldes M.","year":"2003","unstructured":"Moldes M.; Zuo Y.; Morrison R.F.; Silva D.; Park B.H.; Liu J.; Farmer S.R.; Peroxisome-proliferator-activated receptor \u03b3 suppresses Wnt\/\u03b2-catenin signalling during adipogenesis. Biochem J 2003,376(3),607-613","journal-title":"Biochem J"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng1679","volume":"38","author":"Rosenbauer F.","year":"2006","unstructured":"Rosenbauer F.; Owens B.M.; Yu L.; Tumang J.R.; Steidl U.; Kutok J.L.; Clayton L.K.; Wagner K.; Scheller M.; Iwasaki H.; Liu C.; Hackanson B.; Akashi K.; Leutz A.; Rothstein T.L.; Plass C.; Tenen D.G.; Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat Genet 2006,38(1),27-37","journal-title":"Nat Genet"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.exphem.2008.01.015","volume":"36","author":"Hirouchi T.","year":"2008","unstructured":"Hirouchi T.; Takabatake T.; Yoshida K.; Nitta Y.; Nakamura M.; Tanaka S.; Ichinohe K.; Oghiso Y.; Tanaka K.; Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice. Exp Hematol 2008,36(7),871-885","journal-title":"Exp Hematol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1172\/JCI2887","volume":"103","author":"Park D.J.","year":"1999","unstructured":"Park D.J.; Chumakov A.M.; Vuong P.T.; Chih D.Y.; Gombart A.F.; Miller W.H.; Koeffler H.P.; CCAAT\/enhancer binding protein \u03b5 is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 1999,103(10),1399-1408","journal-title":"J Clin Invest"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1128\/MCB.02422-06","volume":"27","author":"Yoshida H.","year":"2007","unstructured":"Yoshida H.; Ichikawa H.; Tagata Y.; Katsumoto T.; Ohnishi K.; Akao Y.; Naoe T.; Pandolfi P.P.; Kitabayashi I.; PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C\/EB Pepsilon expression in myeloid differentiation. Mol Cell Biol 2007,27(16),5819-5834","journal-title":"Mol Cell Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/sj.onc.1205400","volume":"21","author":"Hoffman B.","year":"2002","unstructured":"Hoffman B.; Amanullah A.; Shafarenko M.; Liebermann D.A.; The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 2002,21(21),3414-3421","journal-title":"Oncogene"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/cphy.c190014","volume":"10","author":"Coller H.A.","year":"2019","unstructured":"Coller H.A.; Regulation of cell cycle entry and exit: A single cell perspective. Compr Physiol 2019,10(1),317-344","journal-title":"Compr Physiol"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520623666230110121629","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212512\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520623666230110121629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T17:59:38Z","timestamp":1692554378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212512\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520623666230110121629","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}